The invention provides a traditional Chinese medicine composition for treating bronchial asthma in the remission stage. The traditional Chinese medicine composition comprises the following raw materials: radix astragali, ephedra, herba epimedii, fructus psoraleae, semen brassicae, gecko, folium eriobotryae, asarum, tangerine peel, ginseng leaf, fructus gleditsiae sinensis, liriope spicata, Chinese yam, fritillaria cirrhosa, cortex acanthopanacis, knoxia root, negundo chastetree leaf, astragalus complanatus, ganoderma lucidum, conyza blinii, magnolia officinalis, semen coicis, aster, glossy privet fruit, dendrobium nobile and pummelo peel. The traditional Chinese medicine composition provided by the invention has the advantages of being capable of obviously improving the clinical symptoms and signs of the asthma in the remission stage, reducing attack frequency, alleviating attack degree, prolonging attack interval and improving the lung function, thus the asthma is effectively controlled, the survival quality of patients is improved, and the advantages of the traditional Chinese medicine for diagnosing and treating the asthma based on syndrome differentiation are embodied; and compared with the western medicines, the traditional Chinese medicine composition has little toxic and side effects and is low in cost.